Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 13 04:00PM ET
7.10
Dollar change
+0.01
Percentage change
0.14
%
IndexRUT P/E- EPS (ttm)-1.15 Insider Own35.13% Shs Outstand30.44M Perf Week-13.94%
Market Cap216.28M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float19.76M Perf Month-4.70%
Income-35.01M PEG- EPS next Q- Inst Own15.02% Short Float4.29% Perf Quarter11.46%
Sales0.00M P/S- EPS this Y- Inst Trans15.98% Short Ratio17.56 Perf Half Y-17.35%
Book/sh6.46 P/B1.10 EPS next Y- ROA-15.53% Short Interest0.85M Perf Year80.66%
Cash/sh6.19 P/C1.15 EPS next 5Y- ROE-16.44% 52W Range3.51 - 9.96 Perf YTD77.50%
Dividend Est.- P/FCF- EPS past 5Y-6.44% ROI-17.80% 52W High-28.71% Beta1.40
Dividend TTM- Quick Ratio11.13 Sales past 5Y-47.28% Gross Margin-489.67% 52W Low102.28% ATR (14)0.50
Dividend Ex-DateJul 15, 2021 Current Ratio11.13 EPS Y/Y TTM-23.16% Oper. Margin0.00% RSI (14)46.74 Volatility7.83% 6.53%
Employees82 Debt/Eq0.05 Sales Y/Y TTM-100.00% Profit Margin- Recom3.00 Target Price28.00
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-48.68% Payout- Rel Volume0.73 Prev Close7.09
Sales Surprise- EPS Surprise0.00% Sales Q/Q- Earnings- Avg Volume48.32K Price7.10
SMA20-4.05% SMA50-1.59% SMA2001.28% Trades Volume35,117 Change0.14%
Date Action Analyst Rating Change Price Target Change
Jun-14-19Initiated Piper Jaffray Overweight $13
Apr-21-17Downgrade Noble Financial Buy → Hold $13
Jun-28-16Reiterated Noble Financial Buy $24 → $30
Aug-12-24 02:45PM
Jun-18-24 11:35AM
May-13-24 10:53AM
May-10-24 01:05PM
Mar-18-24 03:53PM
09:00AM Loading…
Jan-04-24 09:00AM
Nov-14-23 09:00AM
Sep-26-23 09:00AM
Aug-30-23 09:00AM
Aug-08-23 11:47AM
Jul-25-23 11:53AM
Jun-28-23 10:36AM
May-22-23 09:00AM
May-17-23 09:00AM
Apr-17-23 09:00AM
10:08AM Loading…
Apr-09-23 10:08AM
Feb-15-23 09:29AM
Jan-19-23 08:02AM
Nov-11-22 05:00AM
Oct-31-22 09:41AM
Oct-13-22 12:46PM
Sep-08-22 08:59AM
Aug-12-22 08:38AM
Jun-20-22 09:00AM
May-24-22 09:06AM
Apr-28-22 09:00AM
Mar-15-22 11:00AM
Feb-02-22 09:00AM
Jan-26-22 09:50AM
Jan-10-22 10:18AM
09:45AM Loading…
09:45AM
Dec-15-21 10:37AM
Dec-13-21 08:00AM
Oct-28-21 11:59AM
Sep-14-21 11:48AM
Sep-08-21 09:00AM
Aug-30-21 09:00AM
Jul-30-21 11:03AM
Jul-06-21 04:30PM
Jun-30-21 11:46AM
Jun-29-21 08:04AM
Jun-23-21 08:30AM
Jun-16-21 02:52AM
Jun-08-21 03:16PM
May-19-21 09:31AM
May-03-21 08:00AM
Apr-19-21 07:08AM
04:00AM
Mar-18-21 07:51AM
Feb-26-21 03:26PM
Jan-21-21 08:15AM
Jan-19-21 08:15AM
Nov-29-20 08:14PM
Nov-19-20 08:15AM
Sep-22-20 03:25PM
Sep-21-20 08:20AM
Aug-24-20 10:00AM
08:10AM
Aug-17-20 08:20AM
Jul-22-20 09:20AM
Jul-14-20 09:25AM
Jun-22-20 02:17PM
May-01-20 09:25AM
Apr-17-20 08:45PM
Apr-14-20 09:15AM
Apr-03-20 04:53PM
Feb-19-20 08:15AM
Feb-13-20 01:24PM
08:15AM
Feb-10-20 03:59PM
Jan-15-20 08:22AM
Jan-14-20 08:30AM
Dec-30-19 04:05PM
Dec-20-19 02:53PM
Dec-17-19 08:15AM
Dec-10-19 07:14AM
Dec-07-19 03:05AM
Nov-19-19 08:55AM
Nov-12-19 08:45AM
Oct-23-19 08:15AM
Oct-10-19 02:57PM
Oct-02-19 08:59AM
Sep-27-19 08:15AM
Sep-20-19 08:15AM
Jul-16-19 01:15PM
Jul-11-19 08:30AM
Jul-10-19 08:00AM
Jul-09-19 08:00AM
Jun-26-19 08:30AM
Jun-25-19 08:45AM
Jun-11-19 08:00AM
Jun-04-19 04:01PM
May-31-19 08:47AM
May-30-19 04:32PM
May-23-19 08:20AM
May-13-19 09:27AM
May-02-19 08:15AM
Apr-29-19 07:54AM
Mar-04-19 01:44PM
Mar-01-19 12:54PM
XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.